{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:02:26Z","timestamp":1760144546929,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.cjca.2014.07.748","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T04:15:59Z","timestamp":1408508159000},"page":"1595-1601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Appropriate Revascularization in Stable Angina: Lessons From the BARI 2D Trial"],"prefix":"10.1016","volume":"30","author":[{"given":"Ronald J.","family":"Krone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Althouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-8769","authenticated-orcid":false,"given":"Jacqueline","family":"Tamis-Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-3932","authenticated-orcid":false,"given":"Lakshmi","family":"Venkitachalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Forker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice K.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Ocampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0057-5889","authenticated-orcid":false,"given":"Francisco","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan R.","family":"Pena Sing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Mori","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2014.07.748_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.07.748_bib2","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0Randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2014.07.748_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archinternmed.2011.1484","article-title":"Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials","volume":"172","author":"Stergiopoulos","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2014.07.748_bib4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2011.12.001","volume":"59","author":"Patel","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.748_bib5","first-page":"53","article-title":"Appropriateness of percutaneous coronary intervention","volume":"306","author":"Chan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.07.748_bib6","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.2011.601","article-title":"Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention","volume":"305","author":"Borden","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2014.07.748_bib7","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2337\/diacare.27.8.1954","article-title":"Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study","volume":"27","author":"Wackers","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2014.07.748_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7326\/0003-4819-108-2-170","article-title":"Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy","volume":"108","author":"Nesto","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2014.07.748_bib9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjcard.2008.11.024","article-title":"Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D)","volume":"103","author":"Schwartz","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.748_bib10","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1161\/CIRCULATIONAHA.112.092973","article-title":"Clinical and angiographic risk stratification and differential impact on treatment outcomes in the BARI 2D trial","volume":"126","author":"Brooks","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.748_bib11","doi-asserted-by":"crossref","first-page":"41G","DOI":"10.1016\/j.amjcard.2006.03.012","article-title":"Modifications of coronary risk factors","volume":"97","author":"Albu","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.748_bib12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.amjcard.2010.11.020","article-title":"Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial)","volume":"107","author":"Tamis-Holland","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.748_bib13","doi-asserted-by":"crossref","first-page":"31G","DOI":"10.1016\/j.amjcard.2006.03.011","article-title":"Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D)","volume":"97","author":"Barsness","year":"2006","journal-title":"Trial. Am J Cardiol"},{"key":"10.1016\/j.cjca.2014.07.748_bib14","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jacc.2012.07.012","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2014.07.748_bib15","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/CIRCULATIONAHA.110.978247","article-title":"Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease","volume":"123","author":"Dagenais","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.748_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCOUTCOMES.113.000139","article-title":"Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial","volume":"6","author":"Spertus","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2014.07.748_bib17","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/CIRCULATIONAHA.109.912642","article-title":"Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial","volume":"122","author":"Brooks","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2014.07.748_bib18","first-page":"1159","article-title":"Diagnosis and prognosis of silent ischemia","volume":"43","author":"Krone","year":"1998","journal-title":"Cardiologia"},{"key":"10.1016\/j.cjca.2014.07.748_bib19","first-page":"696","article-title":"Ad hoc percutaneous coronary interventions in patients with stable coronary artery disease\u2014prevalence, safety, and variation in use from the ACC-NCDR","volume":"68","author":"Krone","year":"2006","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14012768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X14012768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:38:07Z","timestamp":1760107087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X14012768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0828282X14012768"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2014.07.748","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriate Revascularization in Stable Angina: Lessons From the BARI 2D Trial","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2014.07.748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}